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A socio-biological explanation for social disparities in
non-communicable chronic diseases: the product
of history?
C M Schooling, G M Leung
ABSTRACT
This study places social disparities in the major
non-communicable chronic diseases within their global
economic and historical contexts. Rapid economic
transition outside the developed world provides a unique
opportunity to re-examine the origins of, and biological
mechanisms driving, social disparities. Gaps in prevailing
theories focusing on material resources, civic
infrastructure and social structure are identified. Using
longstanding experimental evidence and epigenetic
theories, it is suggested that exposure to economic
development over generations (ie, improved living
conditions over historical time) could by acting on
different biological axes (somatotrophic and
gonadotrophic) generate specific patterns of social
disparities. Moreover, these same processes could
initially generate a transient epidemic of diabetes as well
as a permanent increase in male risk of premature
ischaemic heart disease. As such, this study
demonstrates the importance of context, and implies
that current evidence from the developed world may be
largely uninformative for preventing or mitigating social
disparities in non-communicable chronic diseases
elsewhere, suggesting research efforts should be
focused on developing countries.
INTRODUCTION
Social disparities in health are pervasive and
persistent. Impoverished environments indisput-
ably lead to ill health, emphasising the importance
of environmental conditions, encompassing mate-
rial resources, civic infrastructure and social struc-
ture. Key to mitigating the effects of social
disparities on health, indeed of any environmental
threats, is to understand completely the aetiologic
pathways through which adverse consequences are
generated. Although the literature is populated
with explanations for the multiple pathways by
which the embodiment of lack of resources, social
exclusion and discrimination may damage health,1
there are important gaps.
Social disparities have been most extensively
documented in developed countries, albeit from
different perspectives. In the USA, emphasis was
initially on racial disparities in health,2 perhaps
because of the civil rights movement and ideal of
a classless society. In contrast, in the UK, greater
emphasis has been placed on socio-economic
disparities in health, at least since the 1980 Black
Report3 in the present era. Despite political oppo-
sition, the underlying explanation is recognised as
deprivation,4 although which of the multiple
dimensions of deprivation are most important in
generating disparities is difﬁcult to distinguish from
inevitably observational studies. Nevertheless, lack
of personal resources and public infrastructure5
throughout life are recognised as important
factors,4 with a heated debate as to whether a neo-
material explanation is sufﬁcient or whether
depletion of social capital, stresses of low status or
prestige, lack of power or invidious comparisons
also make a difference.5e9 This debate is difﬁcult to
resolve because the processes and pathways by
which social disparities generate diseases are not
fully elucidated. However, it is increasingly impor-
tant for non-communicable chronic diseases in the
developing world. With economic development,
rising national incomes and the associated changes
in life expectancy, nutrition and lifestyle, chronic
diseases are expected to be responsible for an
increasing share of global deaths in developing
countries over the next 20 years.10
Most current theories concerning disparities in
chronic disease originate from observations in long-
term developed Caucasian populations. Evolution
of disparities over time in parallel with economic
development, either considered as historical time or
as epidemiological time relative to the start of
economic development, is not usually considered.
This missing dimension may result in empirically
driven hypotheses, which are inappropriate for, or
easily disproved in, populations with different
histories of economic development. Current rapid
economic development and industrialisation in the
developing world provides a unique opportunity to
re-examine the origins and biological mechanisms
driving social disparities. Below, social disparities in
the major non-communicable diseases (ie, cardio-
vascular diseases (ischaemic heart disease (IHD)
and stroke) and diabetes) are placed within their
global and historical contexts, which may provide
clues as to how the emergence of these disparities
can be prevented and/or mitigated most effectively
in transitioning economies.
GLOBAL CONTEXT
Disparities between countries
Figure 1 shows the current association between
national income (gross domestic product (GDP) per
head11) and mortality (age-standardised mortality
per 100 000) from stroke and IHD, where available
(153 countries).12 Figure 2 shows the current asso-
ciation between national income and morbidity
from diabetes (age-standardised disability adjusted
life years per 100 00012) for these same countries.13
In all cases, assessed frommodelﬁt (data not shown),
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curvilinear relationships (as shown), obtained using fractional
polynomials, captured the associations better than purely linear
relationships. Morbidity is shown in preference to mortality for
diabetes, because diabetes is not usually recorded as the cause of
death.
Stroke mortality is consistently negatively associated with
national income, with possibly a stronger association at higher
levels of national income. In contrast, low levels of national
income are positively, albeit weakly, associated with IHD and
diabetes, which changes to a negative association at medium to
high levels for IHD and diabetes. Similarly, biological risk
factors, such as cholesterol or obesity are positively associated
with national income at low income levels, but negatively at
high levels, whereas blood pressure has little clear association
with national income.14 15
Disparities within countries
Somewhat similar to between country disparities, within
countries at an individual level there is often a reverse social
gradient at low levels of national income and the usual negative
association between disease and socio-economic position at high
levels of national income for IHD16e23 and diabetes.24e37
Moreover, there often appears to be a more marked reverse
gradient for men, which is evident at higher levels of national
income for IHD.16 38e41 There are also similar patterns for bio-
logical risk factors, such as obesity15 42 43 and hypertension,44 45
with again a more marked reverse gradient among men for
obesity.15 42 43
Overall, it appears that the pattern of disparities may vary by
disease and sex as well as changing over epidemiological time,
with stroke perhaps having the most consistent association with
poverty. However, global disparities between and within coun-
tries are limited by being inevitably contemporaneous, hence the
need to consider trends over time.
HISTORICAL CONTEXT
Secular trends
Congruent with the disease-speciﬁc patterns of disparities
between countries by national income, there appear to be
disease-speciﬁc secular trends accompanying economic develop-
ment over historical time, that is, with epidemiological time.
First, the epidemiological transition of stroke usually involves
two opposite trends; haemorrhagic stroke declines, whereas
ischaemic stroke increases. This trend was observed for stroke
mortality over the 20th century in a long-term developed
country, the UK,46 and more recently for stroke morbidity in one
of the most developed areas of a rapidly developing country,
Beijing, China.47 Second, recent economic development (via
economic growth or migration) appears to be associated with
diabetes in men and women, with little change in the sex ratio
over time.48 This is currently the case in Asia, with its history of
recent economic development.49 It is also evident for migrants
from economically less to more developed locations, such as
Hispanics in the USA50 or southern Europeans in Australia.51
Whether such an epidemic is a permanent attribute of that
population or the product of history is difﬁcult to ascertain. It is
perhaps noteworthy that following the Jewish exodus from
Russia in the late 19th century to the north-eastern US cities,
Jews were in the early 20th century transiently more prone to
diabetes.52 53 Third, the increase in IHD mortality only occured
after many decades of economic development. In the USA and
the UK economic growth started in the late 18th century,11 54
but only in the early 20th century did an epidemic of IHD take
place.55 56 Similarly, in sub-Saharan Africa, in some Chinese
populations with a short history of economic development and
in ﬁrst generation migrants from economically less to more
developed locations, IHD has not risen strongly, although
Figure 1 Mortality from stroke (left) and ischaemic heart disease (IHD) (right) by national income (gross domestic product (GDP) per capita).
Figure 2 Morbidity from diabetes (disability adjusted life years
(DALYs)) by national income (gross domestic product (GDP) per capita).
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diabetes has.57e61 Moreover, when this epidemic of premature
IHD does occur, it is usually limited to men,55 for reasons that
are unclear.
Coincident with these secular trends in disease patterns with
epidemiological time, there are also long-term, though not
simultaneous, secular trends towards greater height,62 larger
frame size63 and earlier age at sexual maturity.62 64 Greater
height, and particularly longer legs, is usually associated with
lower risk of common non-communicable diseases, such as
stroke, diabetes and IHD.65e80 However, again these associations
appear to vary with disease and epidemiological time.
Congruent with the consistent negative association between
stroke and national income, this negative association is most
consistent for stroke,65e70 and less consistent for diabetes, IHD
or its component risk factors,68e70 81e85 particularly in popula-
tions with a short history of economic development. Height also
has incoherent associations with IHD at individual and popu-
lation levels.
Disparities over historic time
In contrast to the secular trends observed over epidemiological
time since the start of economic development, information
concerning changes over historical time is less well documented
and may relate to periods preceding economic development
when the infrastructure to collect such information was not in
place. Health disparities are usually considered to have been
consistent over historical time,86 although their extent in Europe
before the start of the Industrial Revolution is unclear,86 and
virtually unknown elsewhere. However, disease-speciﬁc secular
trends alone would be expected to produce varying patterns of
disparities. Historical evidence concerning disparities is limited.
Nevertheless, consistent with the change in the pattern of
disparities with epidemiological time, there is some evidence
that racial and socio-economic disparities have changed over
historic time. Diabetes was well known in Europe and the USA
in the 19th century. At the end of the 19th century black people
in the USA had lower rates of diabetes than white people,53
a reversal of the current situation.53 In the 20th century, the
pattern of social disparities in male IHD reversed from an
association with higher social position to an association with
lower social position,87 although this initial positive association
between IHD and social advantage could have been the result of
systematically differential diagnosis.88 However, there is less
evidence that this reversal took place for women,88 consistent
with the lack of an epidemic of IHD in women at the later
stages of economic development.55
EXPLANATIONS
There are several explanations commonly given for the inco-
herence of individual-level and between-population disparities in
these diseases, globally and historically with economic devel-
opment. Global disparities may be explained by genetic differ-
ences, the thrifty genotype89 or the thrifty phenotype.90 To date,
the genetics of diabetes and IHD are still being explored.91e93
Promising candidate genes have been found, mainly among
European populations, although whether these also explain
global disparities is not yet known. In contrast, there is less
genetic evidence for the thrifty phenotype hypothesis,94 95
which has also been challenged from anthropological96 and
racial97 perspectives. Moreover, genetic explanations do not
provide any insight into disparities within countries. It is also
unlikely that the disadvantaged are also genetically disposed
towards these diseases. Arguably the disadvantaged might be
more liable to environmental change over their lifetimes, making
them more vulnerable to environmental ‘mismatch’ with its
hypothesised consequences.98 However, evidence for that
hypothesis mainly comes from small animals.99e101 In humans,
social mobility, which equates to life course mismatched envi-
ronments, carries no risk for cardiovascular disease beyond that
of its component parts.102
Reversals in the social gradient of disease with economic
development over historical time are usually explained in terms
of inequalities in access to the beneﬁts of economic development
and changing social constructs of the value of body size. In low-
income countries, access to the lifestyle (more food, smoking,
physical inactivity) associated with cardiovascular disease or
diabetes may be restricted to the advantaged, giving a reverse
social gradient, which later reverses as the beneﬁts of economic
development spread to less advantaged sections of populations.
Similarly, in low-income countries larger, and fatter, body sizes
may be valued when restricted to the more advantaged, but less
valued when more widely accessible. Moreover, these social
constructs and social norms concerning body size may be
different for men and women, such that the social gradient
changes more quickly for women than men. Finally, lifestyle
changes in diet and physical activity with economic develop-
ment may have a more immediate impact on glucose metabo-
lism and diabetes than on IHD. The weaknesses with an
explanation essentially premised on access to resources and
social constructs are ﬁvefold. First, the pattern of these diseases
is heterogeneous over epidemiological time, necessitating
a speciﬁc, but as yet unknown, sequence of lifestyle changes.
Second, the pattern of change with epidemiological time varies
with sex, necessitating sex-speciﬁc changes in lifestyle perhaps
driven by changing social constructs of body shape. However, in
long-term developed countries some of these changes took place
largely before the current epidemic of obesity. Third, these
diseases may share risk factors, but that does not imply they
share causes. Fourth, this explanation in terms of lifestyle gives
no insight into why there have been extended secular trends
over time. Fifth, a lifestyle explanation may also imply that
a common infection does not underlie social disparities, because
the same group of people, most likely, are the ﬁrst ones in their
societies to experience socio-economic development with access
to associated amenities (including running water) and to expe-
rience diabetes and heart disease, suggesting that infection is
an unlikely causative agent, although more plausibly so for
haemorrhagic stroke.
Other possible reasons for the incoherence of individual-level
and between-population disparities globally and historically
may provide insight into how disparities have originated and
more importantly can be prevented, particularly in the devel-
oping world. It is becoming increasingly evident that there
may be non-genomic biological mechanisms that transmit
environmental inﬂuences on health across generations, that is,
intergenerational effects. Such mechanisms provide a framework
that would generate changes over many generations, with
patterns of health varying with the number of generations since
the start of economic development (eg, the Industrial Revolu-
tion or other similar watershed developmental milestones in
more recently developed or developing economies), because of
the long-range effect of living conditions in earlier generations.
Such intergenerational effects would also generate effects
contingent on the stage of the epidemiological transition. Below,
it is tentatively suggested how framing within a historical
context, including intergenerational effects, may provide fresh
insights concerning disparities in some major non-communi-
cable chronic diseases.
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A socio-biological thesis
Well-documented and extended changes over epidemiological
time in height, frame size and build suggest that consideration
of intergenerationally and environmentally driven changes
during growth to the associated somatotrophic and gonadotro-
phic axes might provide a starting point for a socio-biological
explanation of long-range changes in chronic diseases. Moreover,
any associated differences in chronic disease risk factors at the
termination of growth would be expected to track into adult
life.103 The biological mechanisms underlying intergenerational
changes to these axes are not yet entirely clear, although the
recent rediscovery of non-Mendelian heritable changes in gene
expression driven by the environment in previous generations,
that is, epigenetics, provides a candidate. Moreover there also
appears to be some preliminary evidence that intergenerational
growth conditions may permanently upregulate offspring
hormone levels.104e107 Similarly, hormone levels appear to
increase with epidemiological time.107e109 Very speculatively,
ﬁgure 3 shows schematically how the same exposure (improved
living conditions over generations or historical time) might act
on different biological axes (somatotrophic vs gonadotrophic) to
generate speciﬁc patterns of diseases and disparities over epide-
miological time.
Somatotrophic axis
Epigenetic mechanisms evolved to maximise maternal-offspring
coadaptations, including regulation of postnatal growth.110 111
Different mechanisms control prepubertal and pubertal linear
growth.112 When conditions allow, constrained prepubertal
growth is usually followed by greater pubertal linear growth.113
In a developing or recently developed population, pubertal
growth may respond immediately to better living conditions but
leg length only responds over generations.62 63 Relatively or
absolutely more pubertal linear growth is associated with dia-
betes and/or insulin resistance,80 85 114 most likely due to
changes in the somatotrophic axis, that is, on insulin-like
growth factor/growth hormone. These effects could be exacer-
bated by lack of compensating muscle mass from longer legs and
larger frames.
In this socio-biological historical framework, the ﬁrst genera-
tion to experience better living conditions during growth could
be more vulnerable to diabetes because of compensatory growth
at puberty. That ﬁrst generation will have a reverse social
gradient in diabetes, as those who did not experience improved
conditions would have no compensatory growth at puberty.
Such a pattern has been seen in populations with a very recent
history of economic development over one generation, such as
China,27 India,28 29 Bangladesh,30 Pakistan32 or Eygpt.34
However, this reverse gradient ‘wears off ’ with generations of
economic development, as maternal constraint wears off, as for
example seen in the Chinese population of Hong Kong, who
have a slightly longer history of economic development over one
or two generations,35 or in some countries in South America36 37
with again a slightly longer history of economic development.11
When most people in the population have several generations of
economic development behind them the usual social gradient in
diabetes is seen.24 115 Moreover, all else being equal, rates of
diabetes would be lower in long-term developed populations
than in populations in transition. However, the countervailing
forces of ageing/survivorship and contemporaneous environ-
ment in long-term developed countries are currently conspiring
to keep population rates of diabetes persistently high. Never-
theless, currently, diabetes prevalence in the recently transi-
tioned populations of Asia outstrips rates seen in long-term
developed Western populations.49 Thus, epigenetic constraint
combined with varying levels and histories of economic devel-
opment may potentially generate disparate patterns of dispar-
ities within countries and a disparate pattern of diabetes with
national income, because of higher rates of diabetes in rapidly
transitioning (and usually middle income) populations.
Gonadotrophic axis
Sex-speciﬁc pubertal changes have previously been suggested as
contributing to the earlier development of IHD in men,116
because pubertal sex-steroids act on key IHD risk factors.
Pubertal sex-steroids reduce lower HDL cholesterol and increase
android fat patterning in boys, with the opposite effects in
girls.116e128 Diabetes risk is less sex-speciﬁcally affected by
pubertal sex-steroids.124e128 Whether sexual dimorphism in
blood pressure also arises at puberty,129 130 similarly due to the
action of sex-steroids is less clear. These pubertal changes have
generally been assumed to be a universal environmentally
independent feature of growth and development. However, sex-
differences in HDL cholesterol are contextually speciﬁc,
suggesting environmental inﬂuences.131 Moreover, experimental
evidence suggests that pubertal sex-steroids are dietary and
possibly intergenerationally driven; in animals underfeeding
reduces testosterone132e134 and oestrogen135 at puberty. Even in
universally well-fed human populations in the West, slight
changes in diet affect sex-steroids in girls136 but not in boys,137
Figure 3 Schematic outline of how
socio-historical processes have
biological effects on non-communicable
chronic diseases over epidemiological
time. IHD, ischaemic heart disease.
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although larger changes between environments may make
a difference.138 In rats, maternal food restriction during late
pregnancy and lactation drastically reduces testicular size,139with
potential consequences at puberty. As would be expected from
a dietary-driven process, the pattern of pubertal development is
different in developed environments140 as opposed to very poor
environments,138 and has changed over historical time.141
In this alternative, less Western-centric, conceptualisation,
economic development permanently upregulates the gonado-
trophic axis via pubertal nutrition with corresponding inter-
generational effects. Higher levels of pubertal sex-steroids have
sex-speciﬁc effects on IHD mediated by central obesity and
lipids. Hence, a sex-speciﬁc pattern of disparities in IHD would
be expected to emerge with economic development. As with
diabetes, in the early stages of economic development it is likely
to be the advantaged who are initially at increased risk of IHD,
hence the reverse gradient in IHD observed for men but less so in
women.16 88 This sexually dimorphic pattern of social disparities
in IHD, obesity and/or lipids, but not diabetes, in the ﬁrst few
generations to experience economic development has been
observed in a recent study from a developing population,142
where the generally protective effect of social advantage was
obscured for these risk factors in men. Similarly, there are many
studies from long-term developed countries showing a usually
unexplained or weaker social gradient for men than women in
obesity, lipids and IHD,15 16 39 40 with particularly marked
differences in disparities by sex for populations at an earlier stage
of economic development or with a shorter history of economic
development.38 41 Finally, the implication of this conceptuali-
sation is that higher IHD mortality in men is partly an epide-
miologically stage-speciﬁc product of growth in an economically
developed environment. Seminal epidemiological studies in the
1970s of Japanese men who had migrated to the USA found that
‘Westernisation’ during childhood was a key exposure driving
IHD.143 144 More recent studies of migration within China have
replicated these observations and indicated that they are speciﬁc
to men.145e147 Vulnerability to premature IHD in men may not
be an immutable sex difference, but a disparity resulting from
socio-economic development.
LIMITATIONS
Although this conceptualisation uses largely known physiolog-
ical evidence to provide a socio-biological explanation for the
observed trends in aggregate and disaggregated disparities in
some major non-communicable chronic diseases, key gaps and
limitations remain. First, the biological basis for the epigenetic
mechanisms that constrain infant and childhood growth have
yet to be mapped out, although there is epidemiological evidence
of such constraint.148e151 Second, it is a supposition that these
epigenetic mechanisms act via the somatotrophic axis; however,
growth hormone is more important to prepubertal than pubertal
growth.152 Third, it is not clear in this framework why
improved living conditions in the ﬁrst generation should have
less effect on IHD, obesity and lipids than on diabetes. However,
in that ﬁrst generation there would not be any additional
contribution to the gonadotrophic axis from maternal hormone
levels and it is possible that differences in the somatotrophic axis
may alter the tempo of pubertal development.153 Fourth, it is
also largely unknown how maternal sex-steroids may affect
pubertal sex-steroids in her offspring. Fifth, this framework
provides no insight about a key risk factor for non-communi-
cable chronic diseases, that is blood pressure, because it is not
clear how blood pressure ﬁts into this framework. There is no
clear global pattern to blood pressure.14 Biologically and epide-
miologically it is not clear how blood pressure is affected by
puberty.129 130 142 Sixth, this conceptualisation has not consid-
ered the effects of interplays between the somatotrophic and
gonadotrophic axes during growth, such as upregulation of the
gonadotrophic axis increasing peak pubertal mass muscle mass
and thereby reducing the long-term risk of diabetes.154 Seventh,
intergenerational upregulation of the gonadotrophic axis with
epidemiological time would be expected to have many other
impacts on population health and disparities because of the plei-
otrophic effects of pubertal sex-steroids. Intergenerational
increases in pubertal sex-steroids could underlie other features of
the epidemiological transition, such as higher rates of female
hormonally related cancers mediated by oestrogen.155 Similarly,
higher levels of pubertal sex-steroids would be expected to have
sex-speciﬁc immunomodulatory effects possibly making men
more vulnerable to inﬂammation and infection,156 possibly with
lifelong effects. Eighth, it is quite possible that with economic
development and the associated socially patterned reductions in
infectious diseases and increases in life expectancy, the relation-
ship between acute and chronic diseases may itself drive some of
the patterns of disparities in chronic diseases. However, it is not
obvious why socially patterned survival should produce disease or
sex-speciﬁc disparities, nevertheless such a possibility cannot be
ruled out. Ninth, the present theoretical framework does not
provide direct insight into the processes that are currently gener-
ating associated epidemics of obesity and diabetes in long-term
developed countries, because the focus is aimed at explaining the
pattern of social disparities and disease that emerges with
economic development. As such the present framework may be
most relevant to developing countries, especially those under-
going rapid change. Finally, this conceptualisation in no way
negates the multidimensional role of deprivation in generating
disparities. Instead, this conceptualisation simply seeks to add
a dimension across time and to drawattention to the off-diagonals
to generate new hypotheses. For example, it suggests that one
exposure (improved living conditions over generations) has
long-term effects on two different biological axes. Coincident
changes to these two axes may generate a myriad of non-causal
associations.
Several of the limitations concerning the hypothesised bio-
logical mechanisms could be addressed by a research programme
using animal models supplemented by observations of adoles-
cents. To the authors’ knowledge, no previous study has moni-
tored in small animals, taken from a constrained environment,
what changes in size, build, metabolic parameters, immune
function and to the gonadotrophic and somatotrophic axes
occur with each successive generation of exposure to a more
‘Westernised’ environment for a varying number of generations.
Such an experiment would test the present hypothesis by
mimicking different trajectories of economic development over
a fairly short timescale. Alternatively, tracking size, muscle
mass, metabolic parameters, immune function and sex-steroids
through puberty in a well-characterised birth cohort whose
members had different family histories of economic develop-
ment would also provide insights within a reasonably short
timescale. Furthermore, evidence from such studies could be
used to inform policies to reduce disparities.
Public health implications
This conceptualisation represents a move away from black box
risk factor epidemiology, with its tangled web of associations,
towards a more aetiological approach and thus the prospect of
more focused interventions with potentially a better under-
standing of any unintended consequences. Most obviously, it
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focuses attention on puberty as a key window of intervention to
prevent disparities arising. However, it also suggests that one
generic intervention will not necessarily have similar effects
across all non-communicable chronic diseases. Instead, any
intervention should be grounded in a contextually speciﬁc
assessment of which non-communicable chronic disease is
forecast to be most salient for the current generation of children,
backed up by a detailed assessment of their current living
conditions and any potential impacts on long-term health.
Speciﬁcally, a comparative examination of the effect of pubertal
nutrition on body composition and chronic disease risk factors
in children growing up in the developing world would be
informative. Moreover, it is also quite possible that such an
assessment may indicate that sex or disease-speciﬁc policies are
warranted, for example, a focus on boys or lifelong diabetes
prevention may have the greatest impact. Systematic surveil-
lance programmes monitoring children’s lifestyle and health in
developing countries, alongside focused investigation of speciﬁc
hypotheses, by global organisations, such as the WHO, would
contribute to the global evidence base for development. As
always, countries supporting the economic development of
developing populations should carefully assess, a priori, the
anticipated impact of their policies on long-term health and
tailor their interventions to generate an environment that
promotes optimal child growth. Although it may be tempting or
even justiﬁed after thorough deliberation that, in the short-term,
economic growth and associated gains in life expectancy could
or should be traded off against disparities and the long-term
health of today ’s children, such calculus must be made explicitly
and honestly based on a full understanding of potential environ-
mental impact during growth. Finally, the authors caution
that one must be mindful that the theoretical construct as
presently proposed requires further epidemiologic conﬁrmation
and laboratory-based validation, before it should be relied on to
formulate large-scale interventions or policies. Given these
considerations and the changes in nutrition and physical activity
that have already occurred in some developing countries, immu-
table changes in risk may have already taken place, which
perhaps need to be addressed by healthcare provision as well as
prevention.
CONCLUSION
Despite its tentative and speculative nature, taking a broad
brush approach, this study demonstrates the value of framing
non-communicable chronic disease disparities within a global
and historical perspective. It also implies that evidence from
the Western world at its particular epidemiological stage is
insufﬁcient to interpret the global pattern of disparities,
because patterns of disparities are epidemiologically stage-
speciﬁc. As such, mounting evidence from the developed world
is largely uninformative for the developing world, and instead
there is an ethical imperative to focus research efforts on
developing countries. In particular, examination of southe
south, rather than northesouth, similarities and contrasts,
may be uniquely informative in identifying how economic
transition can be achieved while minimising social disparities.
Perhaps most importantly from a practical point of view,
further investigation of the role of pubertal exposures in the
development of IHD and diabetes is urgently needed, so that
the long-term consequences of the nutrition transition across
life can be assessed and any potential risks averted before
irrevocable changes have taken place throughout the devel-
oping world.
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